Approval · Notice of Compliance 15528 · 2014
OVUGEL: Notice of Compliance 15528
Issued April 25, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15528
- Date
- April 25, 2014
- Company
- Elanco Division Eli Lilly Canada IncGuelph, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Hormone
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OVUGEL | 02424150 | Marketed |
Medicinal ingredients
- TRIPTORELIN ACETATE 100 MCG per ML